Table 5. Effects of UltraRice_original and UltraRice_improved on prevalence of elevated fecal calprotectin (>50 mg/kg).
| Fecal calprotectin >50 mg/kg | |||||
|---|---|---|---|---|---|
| Baseline n/N (%) | 7 months n/N (%) | aOR1 | 95% CI | P value | |
| Placebo | 13/124 (10.5) | 39/101 (38.6) | 1 (ref) | ||
| Any fortified rice | 20/240 (8.3) | 78/243 (32.1) | 0.69 | 0.46 to 1.02 | 0.065 |
| - UltraRice_original | 7/117 (6.0) | 39/121 (32.2) | 0.74 | 0.32 to 1.72 | 0.481 |
| - UltraRice_improved | 13/123 (10.6) | 39/122 (32.0) | 0.66 | 0.29 to 1.51 | 0.324 |
1 From mixed model analyses, adjusted for sex, age (in quartiles), baseline calprotectin >50 mg/kg yes/no, N = 330